| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Rivervest Venture Fund III, L.P. last filed a Form 4 in April 2021, as 10% Owner at OKUR. The filings on record cover 2 companies.
At the last filing, the largest reported position was 2,148,281 shares of SPRB. Net of sales, the SPRB filings show accumulation of 250,000 shares.
Rivervest Venture Fund III, L.P. has 2 Form 4 filings on record from October 2020 to April 2021, across 2 companies: 10% Owner at OnKure Therapeutics (OKUR), 2021; 10% Owner at Spruce Biosciences (SPRB), 2020.
The 6 reported transactions were 4 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $6.8M and no sales.
The largest open-market purchase was 250,000 shares of SPRB at an average $15.00 on October 14, 2020, about $3.8M.
Shares as reported in the last Form 4 for each company; the most recent is from April 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.